BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 30519000)

  • 21. The Effects Of Sevoflurane On The Progression And Cisplatinum Sensitivity Of Cervical Cancer Cells.
    Xue F; Xu Y; Song Y; Zhang W; Li R; Zhu X
    Drug Des Devel Ther; 2019; 13():3919-3928. PubMed ID: 31819366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fucoidan upregulates TLR4/CHOP-mediated caspase-3 and PARP activation to enhance cisplatin-induced cytotoxicity in human lung cancer cells.
    Hsu HY; Lin TY; Hu CH; Shu DTF; Lu MK
    Cancer Lett; 2018 Sep; 432():112-120. PubMed ID: 29746926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting mitochondrial respiration as a therapeutic strategy for cervical cancer.
    Tian S; Chen H; Tan W
    Biochem Biophys Res Commun; 2018 May; 499(4):1019-1024. PubMed ID: 29630860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TMC120 displayed potent cytotoxic effect on human cervical carcinoma through enhancing the polymerization of microtubules.
    Shi L; Yu L; Zhong D; Gu C; Lv L; Zeng X; Yao X; Li L; Liu S
    AIDS; 2018 Jun; 32(9):1107-1114. PubMed ID: 29596107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study on the sensitivity of primary tumor cells of patients with cervical cancer to chemotherapeutic combinations.
    Qiu F; Zhao X
    J BUON; 2018; 23(1):117-123. PubMed ID: 29552770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciprofloxacin triggers the apoptosis of human triple-negative breast cancer MDA-MB-231 cells via the p53/Bax/Bcl-2 signaling pathway.
    Beberok A; Wrześniok D; Rok J; Rzepka Z; Respondek M; Buszman E
    Int J Oncol; 2018 May; 52(5):1727-1737. PubMed ID: 29532860
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
    Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
    J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent progress in synergistic chemotherapy and phototherapy by targeted drug delivery systems for cancer treatment.
    Cao J; Chen Z; Chi J; Sun Y; Sun Y
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):817-830. PubMed ID: 29405791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caspase-dependent apoptosis induced by two synthetic halogenated flavanones, 3',7-dichloroflavanone and 3',6-dichloroflavanone, on human breast and prostate cancer cells.
    Safavi M; Shakeri R; Ardestani SK; Davoodi J; Ajdary S; Foroumadi A
    In Vitro Cell Dev Biol Anim; 2018 Feb; 54(2):136-146. PubMed ID: 29264766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determining the contents and cell origins of apoptotic bodies by flow cytometry.
    Jiang L; Paone S; Caruso S; Atkin-Smith GK; Phan TK; Hulett MD; Poon IKH
    Sci Rep; 2017 Oct; 7(1):14444. PubMed ID: 29089562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus E6 protein enriches the CD55(+) population in cervical cancer cells, promoting radioresistance and cancer aggressiveness.
    Leung TH; Tang HW; Siu MK; Chan DW; Chan KK; Cheung AN; Ngan HY
    J Pathol; 2018 Feb; 244(2):151-163. PubMed ID: 28944962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCL-2 family: integrating stress responses at the ER to control cell demise.
    Pihán P; Carreras-Sureda A; Hetz C
    Cell Death Differ; 2017 Sep; 24(9):1478-1487. PubMed ID: 28622296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors.
    Arosio D; Manzoni L; Corno C; Perego P
    Recent Pat Anticancer Drug Discov; 2017; 12(2):148-168. PubMed ID: 28164756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concurrent chemoradiation versus radiotherapy alone for the treatment of locally advanced cervical cancer in a low-resource setting.
    Pereira E; Cooper HH; Zelaya PG; Creasman W; Price FV; Gupta V; Chuang L
    Gynecol Oncol Rep; 2017 Feb; 19():50-52. PubMed ID: 28116341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell Proliferation and Cytotoxicity Assays.
    Adan A; Kiraz Y; Baran Y
    Curr Pharm Biotechnol; 2016; 17(14):1213-1221. PubMed ID: 27604355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Secondary Antibody-Detecting Molecular Weight Marker with Mouse and Rabbit IgG Fc Linear Epitopes for Western Blot Analysis.
    Lin WW; Chen IJ; Cheng TC; Tung YC; Chu PY; Chuang CH; Hsieh YC; Huang CC; Wang YT; Kao CH; Roffler SR; Cheng TL
    PLoS One; 2016; 11(8):e0160418. PubMed ID: 27494183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advancement and applications of peptide phage display technology in biomedical science.
    Wu CH; Liu IJ; Lu RM; Wu HC
    J Biomed Sci; 2016 Jan; 23():8. PubMed ID: 26786672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow cytometry: basic principles and applications.
    Adan A; Alizada G; Kiraz Y; Baran Y; Nalbant A
    Crit Rev Biotechnol; 2017 Mar; 37(2):163-176. PubMed ID: 26767547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phage display screening identifies a novel peptide to suppress ovarian cancer cells in vitro and in vivo in mouse models.
    Zhou C; Kang J; Wang X; Wei W; Jiang W
    BMC Cancer; 2015 Nov; 15():889. PubMed ID: 26555399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Hippo/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression.
    He C; Mao D; Hua G; Lv X; Chen X; Angeletti PC; Dong J; Remmenga SW; Rodabaugh KJ; Zhou J; Lambert PF; Yang P; Davis JS; Wang C
    EMBO Mol Med; 2015 Nov; 7(11):1426-49. PubMed ID: 26417066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.